Proprietary Cationic Lipo-Oligopeptides Inhibit Herpes Simplex Virus-1 Infection
The use of antimicrobial peptides (AMPs) to combat herpes simplex virus type 1 (HSV-1) infection has surged amidst the rise of HSV-1 drug-resistant strains. AMPs offer an unconventional approach to combat HSV-1 infection by exerting their activity on multiple phases of the viral life cycle, while exhibiting low rates o...